2025 Regular Session
Overview
At the request of: | (at the request of Dr. John Kitzhaber, M.D.) |
Chief Sponsors: | Representative Bowman |
Regular Sponsors: | Representative Diehl |
Bill Title: | Relating to medical treatments with investigational products. |
Catchline/Summary: | Creates a method by which a health care practitioner may offer to treat a patient who has a terminal disease or severe chronic disease with an investigational product not approved by the United States Food and Drug Administration. |
Chapter Number: | |
Fiscal Impact: | May Have Fiscal Impact, But No Statement Yet Issued |
Revenue Impact: | May Have Revenue Impact, But No Statement Yet Issued |
Measure Analysis: | Staff Measure Summary / Impact Statements |
Current Location: | In House Committee |
Current Committee: | House Committee On Behavioral Health and Health Care |
Current Subcommittee: | |
Subsequent Referral(s): |
|
Potential Conflicts of Interest/Vote Explanations: | Potential Conflicts of Interest/Vote Explanation Documents |